search icon
nwbo-img

Northwest Biotherapeutics Inc Share Price

NWBO
PNK
$0.2651
-$0.02
(-7.02%)
1D
Industry: Biotechnology Sector: Health Care

Northwest Biotherapeutics Inc Analyst Forecast

Northwest Biotherapeutics Inc Share Price Chart

Northwest Biotherapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$448.80M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.84M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.85
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.17 L
$0.48 H
$0.2651

About Northwest Biotherapeutics Inc, Common Stock

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inoperable solid tumors, as well as a range of types of cancers. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland. more

Industry: BiotechnologySector: Health Care

Northwest Biotherapeutics Inc Stock Returns

Time FrameNWBOSectorS&P500
1-Week Return-8.59%-0.14%-0.85%
1-Month Return-17.16%-0.61%0.27%
3-Month Return6.04%6.2%2.12%
6-Month Return6.04%15.86%9.31%
1-Year Return-8.59%4.8%14.6%
3-Year Return-64.18%16.79%68.36%
5-Year Return-83.22%33.47%78.62%
10-Year Return-87.5%134.62%261.11%

Northwest Biotherapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.29M1.00M1.68M1.93M1.38M[{"date":"2020-12-31","value":66.82,"profit":true},{"date":"2021-12-31","value":52.02,"profit":true},{"date":"2022-12-31","value":87.11,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":71.53,"profit":true}]
Cost of Revenue87.90M53.71M---[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":61.1,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(86.61M)(52.70M)---[{"date":"2020-12-31","value":-8660500000,"profit":false},{"date":"2021-12-31","value":-5270200000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin(6708.37%)(5243.98%)---[{"date":"2020-12-31","value":-6708.37,"profit":false},{"date":"2021-12-31","value":-5243.98,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses87.90M53.71M68.86M57.44M67.89M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":61.1,"profit":true},{"date":"2022-12-31","value":78.35,"profit":true},{"date":"2023-12-31","value":65.35,"profit":true},{"date":"2024-12-31","value":77.24,"profit":true}]
Operating Income(86.61M)(52.70M)(67.18M)(55.51M)(66.51M)[{"date":"2020-12-31","value":-8660500000,"profit":false},{"date":"2021-12-31","value":-5270200000,"profit":false},{"date":"2022-12-31","value":-6718100000,"profit":false},{"date":"2023-12-31","value":-5550800000,"profit":false},{"date":"2024-12-31","value":-6650800000,"profit":false}]
Total Non-Operating Income/Expense(443.22M)231.83M(37.85M)(7.09M)(17.27M)[{"date":"2020-12-31","value":-191.18,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-16.33,"profit":false},{"date":"2023-12-31","value":-3.06,"profit":false},{"date":"2024-12-31","value":-7.45,"profit":false}]
Pre-Tax Income(529.82M)179.13M(105.03M)(62.60M)(83.78M)[{"date":"2020-12-31","value":-295.78,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-58.64,"profit":false},{"date":"2023-12-31","value":-34.95,"profit":false},{"date":"2024-12-31","value":-46.77,"profit":false}]
Income Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(529.82M)179.13M(105.03M)(62.60M)(83.78M)[{"date":"2020-12-31","value":-295.78,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-58.64,"profit":false},{"date":"2023-12-31","value":-34.95,"profit":false},{"date":"2024-12-31","value":-46.77,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(529.82M)179.13M(105.03M)(62.60M)(83.78M)[{"date":"2020-12-31","value":-295.78,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-58.64,"profit":false},{"date":"2023-12-31","value":-34.95,"profit":false},{"date":"2024-12-31","value":-46.77,"profit":false}]
EPS (Diluted)(0.76)0.19(0.10)(0.06)(0.07)[{"date":"2020-12-31","value":-404.45,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-51.14,"profit":false},{"date":"2023-12-31","value":-30.21,"profit":false},{"date":"2024-12-31","value":-35.24,"profit":false}]

Northwest Biotherapeutics Inc Ratios

Northwest Biotherapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NWBO
Current Ratio 0.08

Northwest Biotherapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NWBO
ROA (LTM) -135.38%
ROE (LTM) 0.00%

Northwest Biotherapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NWBO
Debt Ratio Lower is generally better. Negative is bad. 4.55
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -3.55

Northwest Biotherapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NWBO
Trailing PE NM
Forward PE NM
P/S (TTM) 476.84
P/B 0.00
Price/FCF NM
EV/R 545.98
EV/Ebitda NM
PEG NM

FAQs

What is Northwest Biotherapeutics Inc share price today?

Northwest Biotherapeutics Inc (NWBO) share price today is $0.2651

Can Indians buy Northwest Biotherapeutics Inc shares?

Yes, Indians can buy shares of Northwest Biotherapeutics Inc (NWBO) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NWBO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Northwest Biotherapeutics Inc be purchased?

Yes, you can purchase fractional shares of Northwest Biotherapeutics Inc (NWBO) via the Vested app. You can start investing in Northwest Biotherapeutics Inc (NWBO) with a minimum investment of $1.

How to invest in Northwest Biotherapeutics Inc shares from India?

You can invest in shares of Northwest Biotherapeutics Inc (NWBO) via Vested in three simple steps:

  • Click on Sign Up or Invest in NWBO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Northwest Biotherapeutics Inc shares
What is Northwest Biotherapeutics Inc 52-week high and low stock price?

The 52-week high price of Northwest Biotherapeutics Inc (NWBO) is $0.48. The 52-week low price of Northwest Biotherapeutics Inc (NWBO) is $0.17.

What is Northwest Biotherapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Northwest Biotherapeutics Inc (NWBO) is

What is Northwest Biotherapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Northwest Biotherapeutics Inc (NWBO) is 0.00

What is Northwest Biotherapeutics Inc dividend yield?

The dividend yield of Northwest Biotherapeutics Inc (NWBO) is 0.00%

What is the Market Cap of Northwest Biotherapeutics Inc?

The market capitalization of Northwest Biotherapeutics Inc (NWBO) is $448.80M

What is Northwest Biotherapeutics Inc's stock symbol?

The stock symbol (or ticker) of Northwest Biotherapeutics Inc is NWBO

How Can Investors Use Northwest Biotherapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Northwest Biotherapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Northwest Biotherapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Northwest Biotherapeutics Inc shares for Indian investors?

When investing in Northwest Biotherapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Northwest Biotherapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Northwest Biotherapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Northwest Biotherapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Northwest Biotherapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top